Skip to main content
. Author manuscript; available in PMC: 2016 May 20.
Published in final edited form as: J Urol. 2012 Nov 19;189(1):352–358. doi: 10.1016/j.juro.2012.08.190

Figure 3.

Figure 3

Group mean content of endomorphin-2 in the lumbosacral and thoracolumbar spinal cord and β-endorphin content in the plasma. Panel A: Endomorphin-2 content in the lumbosacral spinal cord was not significantly altered by the treatments (n=5-8/group). Panel B: Endomorphin-2 content was significantly decreased in the thoracolumbar spinal cord of group ZZ compared to groups AA and AZ (*p≤0.009). Panel C: Endomorphin-2 content in the thoracolumbar spinal cord of AA controls was not significantly different from that in the lumbosacral spinal cord. Panel D: β-endorphin content in plasma was not altered by the treatments (n=14-16/group). AA control data are shown in open bars.